Table 5.
Urinary Excretion | Experimental Groups | |||||
---|---|---|---|---|---|---|
PBS | LDL | oxLDL | ||||
Pre-Injection | Postinjection | Pre-Injection | Postinjection | Pre-Injection | Postinjection | |
Water (mL/24 h) | 8.00 ± 1.00 | 8.00 ± 2.00 | 10.00 ± 1.00 | 12.00 ± 3.00 | 9.00 ± 2.00 | 9.00 ± 1.00 |
TBARS (µmol/24 h) | 67.00 ± 11.00 | 68.00 ± 6.00 | 97.00 ± 8.00 | 96.00 ± 17.00 | 93.00 ± 14.00 | 93.00 ± 12.00 |
8-iso-PGF2α (ng/24 h) | 3.65 ± 1.89 | 3.89 ± 0.98 | 3.39 ± 0.86 | 2.88 ± 0.67 | 3.36 ± 1.57 | 3.00 ± 0.87 |
8-OHdG (µg/24 h) | 1.86 ± 0.13 | 1.85 ± 0.28 | 2.19 ± 0.38 | 2.57 ± 0.83 | 1.78 ± 0.33 | 1.82 ± 0.10 |
Abbreviations: TBARS, thiobarbituric-acid-reactive substances; oxLDL, oxidized LDL; 8-iso-PGF2α; 8-isoprostane; 8-OHdG, 8-hydroxy-2′-deoxyguanosine. Results are expressed as means ± standard error of the means (n = 4 for each group).